investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML

Michele S Redell

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

No posts

Related projects

Javier Adachi

Identification of the Gastro-Intestinal Microbiota in Patients with Leukemia at MD Anderson, in Texas and INEN, Peru

Leukaemia

Hematology and hematologic malignancies

Richard Aplenc

Toxicity Monitoring on Phase III Trials with Administrative Data

Leukaemia

Hematology and hematologic malignancies

Ya-Huei Kuo

HDAC8 Mediated Regulation of Acute Myeloid Leukemia Pathogenesis and Maintenance

Leukaemia

Hematology and hematologic malignancies

Richard Aplenc

Genetic Predictors of AML Treatment Response

Leukaemia

Hematology and hematologic malignancies

William E Evans

Pharmacogenomics of Childhood Leukemia (ALL)

Leukaemia

Hematology and hematologic malignancies

Ronald Hoffman

A New Murine Model for MPN: Pathology and Therapy of NF-E2 Overexpression

Leukaemia

Hematology and hematologic malignancies

Susan L Slager

Genetic Epidemiology Of Chronic Lymphocytic Leukemia

Leukaemia

Hematology and hematologic malignancies

Reuben Kapur

Role of p21 Activated Kinase in Leukemogenesis

Leukaemia

Hematology and hematologic malignancies

Frederick Appelbaum

Adult Leukemia Research Center

Leukaemia

Hematology and hematologic malignancies